The AJMC® Asthma compendium is a comprehensive resource for clinical news and expert insights for the chronic lung disease.
Emerging Care Management Strategies for Severe Asthma: Integrating Biologic Therapy
1.0 Credits / Pulmonology/Respiratory
View More
The Benefits and Challenges of Targeted Treatments in Severe and Uncontrolled Asthma: Opportunities in Managed Care
1.0 Credit / Pulmonology/Respiratory
View More
An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC
2 Credits / Oncology, Pulmonology/Respiratory
View More
Uncovering the Economic Burden of Chronic Cough and the Promising Role of Emerging Targeted Therapies
3.0 Credits / Pulmonology/Respiratory
View More
Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Prediction Model Effective for Community-Acquired Pneumonia in Those With Acute Asthma Exacerbations
November 4th 2023This newly developed prediction model evaluating community-acquired pneumonia risk was noted to demonstrate accuracy, strong discriminatory qualities, and practicability in clinical settings.
Read More
Study Highlights Uneven Symptom Burden in Patients With Uncontrolled vs Controlled Severe Asthma
July 10th 2023An analysis found that patients with uncontrolled severe asthma have a higher symptom burden compared with those whose severe asthma is controlled, highlighting the need for more innovative treatment options to improve asthma control.
Read More
Signs of Depression Linked to mAb Therapy Nonresponse in Patients With Severe Asthma
June 23rd 2023A recent study found that depressive symptoms improved among patients with severe asthma who responded to monoclonal antibody (mAb) therapy, but baseline depression symptoms were associated with lower therapy response rates.
Read More